Trophoblast cell surface antigen 2 (TROP2) is a transmembrane protein with low expression in normal tissues but high levels in HR+/HER2– and triple-negative breast cancer (TNBC), often indicating a poor prognosis. Here, TACSTD2 is linked to triple-negative breast carcinoma.